For the Lupus trial, patient enrolment commenced July 2103, the company expecting the trial to run for 12 months, with initial data on safety, efficacy, increasing dosages expected Q4 2013. We must be getting close, that could account for the increase in interest. We've heard nothing for well over 12 months. I just keep hold of the photo of the 4 rats, 2 of them prevented from from contracting cutaneous lupus.
On the liquidity front, we should just hope that Dr William Garners' move to Peurto Rica is working out and he doesn't need to cash in his chips ( when he resigned from the board he had a massive 60 odd million shares). Maybe shareholders can help him out by buying his book 'Garnering Capital'.
IVX Price at posting:
7.6¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)